Left ventricular diastolic function following myocardial infarction

Jens Jakob Thune1, Scott D Solomon

  • 1Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Insights

Acute myocardial infarction impairs heart

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Cardiac Pathophysiology

Background:

  • Acute myocardial infarction (AMI) significantly reduces left ventricular systolic function due to contractile fiber loss.
  • The impact of AMI on diastolic function is less understood but critically affects cardiac performance.
  • Diastole involves active relaxation and passive filling, both compromised by myocardial ischemia and infarction.

Purpose of the Study:

  • To elucidate the complex relationship between acute myocardial infarction and diastolic dysfunction.
  • To understand how myocardial infarction affects the phases of diastole: active relaxation and passive filling.
  • To correlate changes in diastolic function with adverse outcomes post-myocardial infarction.

Main Methods:

  • Review of physiological mechanisms underlying diastolic dysfunction after myocardial infarction.
  • Analysis of factors influencing left ventricular stiffness, including edema and fibrosis.
  • Correlation of diastolic function impairment with patient comorbidities and clinical outcomes.

Main Results:

  • Myocardial infarction delays active relaxation and alters left ventricular stiffness.
  • Increased interstitial edema and fibrosis contribute to heightened wall stiffness, partially offset by dilation.
  • Impaired diastolic function is linked to a higher incidence of adverse outcomes, especially in patients with comorbidities.

Conclusions:

  • Diastolic dysfunction following myocardial infarction is a significant contributor to adverse outcomes.
  • Comorbid conditions exacerbate diastolic dysfunction and worsen prognosis after infarction.
  • While no specific treatments for post-infarction diastolic dysfunction exist, aldosterone antagonists show potential therapeutic promise.